Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Molecules/REGAVIRUMAB

REGAVIRUMAB

Molecular Identity

REGAVIRUMAB

ChEMBL ID: CHEMBL2107880

AntibodyPhase 2

Mechanism of action: Envelope glycoprotein B inhibitor

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(3)

MCA-C23REGAVIRUMABTI-23

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to REGAVIRUMAB

Loading drug network...

REGAVIRUMAB — Molecular Profile | Crick